On Tuesday, Vir Biotechnology Inc (NASDAQ: VIR) opened higher 2.88% from the last session, before settling in for the closing price of $9.37. Price fluctuations for VIR have ranged from $7.12 to $13.09 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 421.39% over the past five years. Company’s average yearly earnings per share was noted 16.32% at the time writing. With a float of $88.14 million, this company’s outstanding shares have now reached $134.78 million.
Let’s look at the performance matrix of the company that is accounted for 587 employees. In terms of profitability, gross margin is 81.92%, operating margin of -658.31%, and the pretax margin is -685.83%.
Vir Biotechnology Inc (VIR) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Vir Biotechnology Inc is 35.50%, while institutional ownership is 51.35%. The most recent insider transaction that took place on Nov 05 ’24, was worth 22,225. In this transaction EVP and General Counsel of this company sold 2,347 shares at a rate of $9.47, taking the stock ownership to the 61,370 shares. Before that another transaction happened on Nov 01 ’24, when Company’s EVP and General Counsel sold 1,403 for $7.20, making the entire transaction worth $10,107. This insider now owns 63,717 shares in total.
Vir Biotechnology Inc (VIR) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.86 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -1.01) by 0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.77 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 16.32% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.00% during the next five years compared to -34.12% drop over the previous five years of trading.
Vir Biotechnology Inc (NASDAQ: VIR) Trading Performance Indicators
Check out the current performance indicators for Vir Biotechnology Inc (VIR). In the past quarter, the stock posted a quick ratio of 8.94. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 16.75.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.92, a number that is poised to hit -0.86 in the next quarter and is forecasted to reach -3.72 in one year’s time.
Technical Analysis of Vir Biotechnology Inc (VIR)
Vir Biotechnology Inc (NASDAQ: VIR) saw its 5-day average volume 2.4 million, a positive change from its year-to-date volume of 1.02 million. As of the previous 9 days, the stock’s Stochastic %D was 87.91%. Additionally, its Average True Range was 0.46.
During the past 100 days, Vir Biotechnology Inc’s (VIR) raw stochastic average was set at 64.95%, which indicates a significant decrease from 96.18% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 90.85% in the past 14 days, which was higher than the 54.93% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.80, while its 200-day Moving Average is $9.21. Nevertheless, the first resistance level for the watch stands at $9.79 in the near term. At $9.95, the stock is likely to face the second major resistance level. The third major resistance level sits at $10.24. If the price goes on to break the first support level at $9.34, it is likely to go to the next support level at $9.05. Assuming the price breaks the second support level, the third support level stands at $8.89.
Vir Biotechnology Inc (NASDAQ: VIR) Key Stats
There are currently 136,640K shares outstanding in the company with a market cap of 1.32 billion. Presently, the company’s annual sales total 86,180 K according to its annual income of -615,060 K. Last quarter, the company’s sales amounted to 2,380 K and its income totaled -213,720 K.
